Abiopharma

🔍 Bowser Carmen M (Executive)

Company: PEAPACK GLADSTONE FINANCIAL CORP (PGC)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 1,675 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 10,368.02 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | shares_owned_after: 3,617.80
• Sold 1,675 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 1,491 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 1,491.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3

Footnotes:

• F1: On March 20, 2025, the reporting person was granted 1,675 restricted stock units (RSUs), vesting on the one year anniversary of the grant. Upon vesting, each RSU converts into one share of PGC common stock.
• F2: Held indirectly through a rabbi trust pursuant to a non-qualified deferred compensation plan.
• F3: On March 20, 2026, the reporting person was granted 1,491 restricted stock units (RSUs), vesting on the one year anniversary of the grant. Upon vesting, each RSU converts into one share of PGC common stock.